DSM and Roquette change their relationship for bio-based succinic acid production
24 February 2019
Bio-based succinic acid is a valuable platform molecule; used as a chemical building block, it can serve multiple industrial applications as an alternative to petroleum counterparts. Following the successful production of bio-succinic acid under the trademark Biosuccinium since 2012, Reverdia’s parent companies—Royal DSM, a global science-based company in Nutrition, Health and Sustainable Living, and Roquette, a global leader in plant-based ingredients for Food, Nutrition and Health markets—have decided on a strategic shift in the continuing operations of their joint venture.
Effective 1 April 2019, the joint venture Reverdia will be dissolved and the partners will transfer the rights and obligations related to Reverdia’s Biosuccinium plant in Cassano, Italy to Roquette.
Under a non-exclusive license from DSM, Roquette will operate the plant and continue serving customers of Biosuccinium. Customer service, order processing, and marketing and sales will be integrated into Roquette’s existing business to ensure a smooth transition. DSM, the original developer of the Biosuccinium technology, will assume the role of exclusive licensor, in line with its business model in this field.
DSM, the original developer of the Biosuccinium technology, will become the exclusive licensor to strategic customers and other third parties interested in the integration of the Biosuccinium production process into their value chains. DSM’s technology has matured to a point where the roll-out potential is significant enough to warrant a focused effort on licensing.